GOSS Stock Analysis: Buy, Sell, or Hold?

GOSS - Gossamer Bio, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.17
0.01 (4.38%) ▲
5d: +2.63%
30d: -14.68%
90d: -54.07%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026

Get Alerted When GOSS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: GOSS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: GOSS is currently trading at $0.17, which is considered slightly low relative to its 30-day fair value range of $0.16 to $0.23.

Technical Outlook: Technically, GOSS is in a strong uptrend. Immediate support is located at $0.14, while resistance sits at $0.20. The stock is showing strong short-term momentum, up 4.4% recently.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.46 (+2499.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $0.16 - $0.23
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 87.9%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.4%)
  • BULLISH: Trading 2499.8% below Wall St target ($4.46)

Trading Range Analysis

30-Day Trading Range $0.16 - $0.23
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $0.14
Resistance Level $0.20
Current Trend Strong Uptrend
Technical data as of Jun 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.57
Wall Street Target $4.46 (+2499.8%)
Revenue Growth (YoY) 71.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 12:59 AM ET
Data refreshes hourly during market hours. Next update: 1:59 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for GOSS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$88 65 BUY
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$436 54 HOLD
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$549 67 BUY
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$84 59 HOLD
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$58 52 HOLD

Advanced GOSS Option Strategies

Professional options setups generated by AI based on today's GOSS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for GOSS

GOSS Technical Chart GOSS Price Prediction GOSS Earnings Date GOSS Investment Advisor GOSS Fair Price Analyzer GOSS Options Advisor GOSS Options Chain GOSS Options Analysis GOSS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals